Open main menu
Search Ctrl + K
Free Trial
Loading...
Aadi Bioscience, Inc.
Watch
Pharmaceutical Preparations
NASDAQ.AADI
17383 Sunset Avenue, Suite A250, Pacific Palisades, CA, 90272
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
News
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
08 May 25
8-K/A
Financial Statements And Exhibits
31 Mar 25
8-K
Completion Of Acquisition Or Disposition Of Assets, Financial Statements And Exhibits
26 Mar 25
8-K
Results Of Operations And Financial Condition, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Financial Statements And Exhibits
18 Mar 25
8-K
Entry Into A Material Definitive Agreement, Submission Of Matters To A Vote Of Security Holders, Regulation Fd Disclosure, Financial Statements And Exhibits
04 Mar 25
8-K
Entry Into A Material Definitive Agreement, Unregistered Sales Of Equity Securities, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure, Financial Statements And Exhibits
20 Dec 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
06 Nov 24
Ownership
4
Ball Bryan
03 Apr 25
4
Lennon David James
03 Apr 25
4
Giacobello Scott M.
03 Apr 25
4
Dalal Anupam
05 Mar 25
4
Zhao Baiteng
04 Mar 25
4
Dornan David
04 Mar 25
4
Castelein Caley
04 Mar 25
Financials
10-Q
Quarterly Filing
08 May 25
10-Q
Quarterly Filing
06 Nov 24
10-Q
Quarterly Filing
07 Aug 24
10-Q
Quarterly Filing
08 May 24
10-K
Fiscal Year 2024
13 Mar 24
10-Q
Quarterly Filing
08 Nov 23
10-Q
Quarterly Filing
09 Aug 23
Proxies
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
28 Apr 25
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
28 Apr 25
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
19 Feb 25
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
18 Feb 25
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
05 Feb 25
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
30 Dec 24
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
20 Dec 24
Prospectuses and Registrations
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
25 Apr 25
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
28 Mar 25
D
Notice Of An Exempt Offering Of Securities Under Regulation D.
18 Mar 25
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
03 May 24
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
12 Feb 24
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
29 Mar 23
424B3
Prospectus Filed Pursuant To Rule 424(b)(3).
04 Nov 22
Other
SCHEDULE 13G
15 May 25
SCHEDULE 13G/A
15 May 25
ARS
Scanned Paper Annual Report Submission.
28 Apr 25
EFFECT
Notice Of Effectiveness For A Previously Filed Sec Document.
08 Apr 25
S-3
Registration Statement Under The Securities Act.
31 Mar 25
SCHEDULE 13G
11 Mar 25
SCHEDULE 13G
10 Mar 25